See every side of every news story

Published 3 days ago • loading... • Updated 2 days ago

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

Summary by Weatherford Democrat

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the COVID-19 vaccine Spikevax®, targeting the SARS-CoV-2 variant LP.8.1, for active…

5 Articles

5 Articles

milescitystar.com

+2 Reposted by 2 other sources

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the COVID-19 vaccine Spikevax®, targeting the SARS-CoV-2 variant LP.8.1, for active…

3 days ago

Read Full Article

Moderna wins EU approval for updated COVID-19 vaccine - EUROPE SAYS

Spikevax authorised to target LP.8.1 variant ahead of 2025-2026 season Moderna has received marketing authorisation from the European…

2 days ago

Read Full Article

pharmatimes.com

Moderna wins EU approval for updated COVID-19 vaccine

Spikevax authorised to target LP.8.1 variant ahead of 2025-2026 season

2 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources5

Leaning Left3Leaning Right0Center0Last Updated2 days agoBias Distribution

100% Left

Bias Distribution

100% of the sources lean Left

100% Left

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Weatherford Democrat broke the news in 3 days ago on Wednesday, July 30, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics